Originally posted by rskr
View Post
Unconfigured Ad
Collapse
X
-
Hi- I agree, when I said that one has to pick a realistic null distribution I referred to this problem. At most you can say that the observed data doesn't come from a random uniform, normal or whatever distribution. Does it make sense? (I'd like to hear more opinions about the question puggie posted)
-
That is invalid, since you have to pick a distribution to sample from "randomly" IE uniform, normal, poisson etc.Originally posted by dariober View PostHi- Rather than applying the Fisher test, I would perform a (large) number of simulations to produce a distribution of the number of features that colocalize by chance. Then I would see where my observed proportion maps on this null distribution. If it maps towards the tails, than my observation is not due to chance.
I think the tricky problem of this approach is to produce realistic null distributions given the genome under study.
I think this paper and the associated R package GenometriCorr might be useful http://www.ncbi.nlm.nih.gov/pubmed/22693437.
Just some thoughts...
Dario
Leave a comment:
-
thanks for your reply I will look into that. I should also mention that the table I showed above is errornous.
It should be like
900 200
300 1000
So e.g. I have 1200 features, 900 hundred colocalize while 300 dont. Then by 100 random iterations (computer picking random features) I get 200 (averaged) colocalize by chance while 1000 dont.
The numbers are just examples, it was just to show that features for the random simulations are of same size as original data.
Leave a comment:
-
Hi- Rather than applying the Fisher test, I would perform a (large) number of simulations to produce a distribution of the number of features that colocalize by chance. Then I would see where my observed proportion maps on this null distribution. If it maps towards the tails, than my observation is not due to chance.Originally posted by puggie View PostDear Forum Members,
I have been analyzing correlations between ENCODE data and my own data. Specifically I have been looking at overlapping (or intersecting) coordinates between data sets to assess colocalization. Now, I would like to add some statistics to the analysis. The data is basically a number of colocalized features to a number of colocalized features generated by random iterations.
So e.g. I could have something like, 900 colocalize, 300 do not from my data, and then by random iterations 200 localize while 700 dont.
900 200
300 700
Is it strong enough to apply Fisher's exact test or should I opt for something different. I have approx. 60 of such four-value tables for which I need to determine statistical significance.
I appreciate any comments on this
I think the tricky problem of this approach is to produce realistic null distributions given the genome under study.
I think this paper and the associated R package GenometriCorr might be useful http://www.ncbi.nlm.nih.gov/pubmed/22693437.
Just some thoughts...
Dario
Leave a comment:
-
Proper statistical test for high-throughput data correlations?
Dear Forum Members,
I have been analyzing correlations between ENCODE data and my own data. Specifically I have been looking at overlapping (or intersecting) coordinates between data sets to assess colocalization. Now, I would like to add some statistics to the analysis. The data is basically a number of colocalized features to a number of colocalized features generated by random iterations.
So e.g. I could have something like, 900 colocalize, 300 do not from my data, and then by random iterations 200 localize while 700 dont.
900 200
300 700
Is it strong enough to apply Fisher's exact test or should I opt for something different. I have approx. 60 of such four-value tables for which I need to determine statistical significance.
I appreciate any comments on thisTags: None
Latest Articles
Collapse
-
by SEQadmin2
Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?
Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating...-
Channel: Articles
10-14-2026, 09:55 AM -
-
by SEQadmin2
Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.
We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing...-
Channel: Articles
-
ad_right_rmr
Collapse
News
Collapse
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
Started by SEQadmin2, 10-22-2026, 11:13 AM
|
0 responses
37 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 11:13 AM
|
||
|
Started by SEQadmin2, 10-22-2026, 10:48 AM
|
0 responses
28 views
0 reactions
|
Last Post
by SEQadmin2
10-22-2026, 10:48 AM
|
||
|
Started by SEQadmin2, 10-15-2026, 10:52 AM
|
0 responses
41 views
0 reactions
|
Last Post
by SEQadmin2
10-15-2026, 10:52 AM
|
||
|
Started by SEQadmin2, 10-14-2026, 05:39 AM
|
0 responses
45 views
0 reactions
|
Last Post
by SEQadmin2
10-14-2026, 05:39 AM
|
Leave a comment: